US Bancorp
- SEC CIK
- 0000036104
- Latest filing
- Aug 12, 2026
MGX holding history
Metagenomi Therapeutics, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MGX overviewAll 13F holders of MGXFull Q2 2026 holdings
- Shares (Q2 2026)
- 4,500
- Value
- $5.36K
- % of portfolio
- <0.1%
- Quarters held
- 10
- Since Q1 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 4,500 | $5.36K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 4,500 | $6.03K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 4,500 | $7.29K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 4,500 | $10.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 4,500 | $6.66K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 4,500 | $6.12K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 4,500 | $16.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 4,500 | $9.77K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 4,500 | $18.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 4,500 | $47.5K | <0.1% | +4,500 | New | Holders |